Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yuhan Corp (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10107
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yuhan Corp (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API’s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. The company provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers active pharmaceutical ingredients (API) and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. It offers its products and services through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Yuhan Corp (000100) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9
Yuhan Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Yuhan Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Yuhan to Enter into Agreement with GC Pharma 11
Yuhan Enters into Agreement with Syntekabio 12
Sorrento Therapeutics Forms Joint Venture with Yuhan 13
Licensing Agreements 14
Janssen Biotech Enters into Licensing Agreement with Yuhan 14
Yuhan Enters into Licensing Agreement with Samsung Bioepis 15
Yuhan Enters into Licensing Agreement with Bioneer 16
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 17
Equity Offering 18
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 18
Acquisition 20
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 20
Yuhan Corp – Key Competitors 21
Yuhan Corp – Key Employees 22
Yuhan Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Affiliate 24
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Nov 05, 2018: Yuhan licences lung cancer asset to Janssen in $1.25bn deal 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Yuhan Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9
Yuhan Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Yuhan to Enter into Agreement with GC Pharma 11
Yuhan Enters into Agreement with Syntekabio 12
Sorrento Therapeutics Forms Joint Venture with Yuhan 13
Janssen Biotech Enters into Licensing Agreement with Yuhan 14
Yuhan Enters into Licensing Agreement with Samsung Bioepis 15
Yuhan Enters into Licensing Agreement with Bioneer 16
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 17
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 18
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 20
Yuhan Corp, Key Competitors 21
Yuhan Corp, Key Employees 22
Yuhan Corp, Other Locations 23
Yuhan Corp, Subsidiaries 23
Yuhan Corp, Affiliate 24
Yuhan Corp, Joint Venture 24

List of Figures
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Yuhan Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Yuhan Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Yuhan Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Yuhan Corp (000100):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magnotta Winery Corporation:企業の戦略・SWOT・財務情報
    Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report Summary Magnotta Winery Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Niko Resources Ltd (NKO):石油・ガス:M&Aディール及び事業提携情報
    Summary Niko Resources Ltd (Niko Resources) is an independent oil and gas exploration and production company that acquires, explores, develops and produces crude oil and natural gas properties. The company concentrates on value generation in the D6 Block in India. It offers financing options for the …
  • Rotala Plc:企業の戦略・SWOT・財務情報
    Rotala Plc - Strategy, SWOT and Corporate Finance Report Summary Rotala Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Marfrig Global Foods SA:企業の戦略・SWOT・財務情報
    Marfrig Global Foods SA - Strategy, SWOT and Corporate Finance Report Summary Marfrig Global Foods SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dixons Carphone plc:企業のM&A・事業提携・投資動向
    Dixons Carphone plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dixons Carphone plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Gujarat State Electricity Corporation Ltd:企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Aurora Health Care Inc:企業の戦略的SWOT分析
    Aurora Health Care Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NHPC Ltd (NHPC):企業の財務・戦略的SWOT分析
    NHPC Ltd (NHPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Baylor Scott & White Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Baylor Scott & White Health (Baylor Scott & White) is a not-for-profit healthcare service provider that offers medical care services. The organization offers medical education, medical services and conducts medical research. It offers medical services in the areas of emergency care, cancer c …
  • Enphase Energy, Inc. (ENPH):電力:M&Aディール及び事業提携情報
    Summary Enphase Energy, Inc. (EEI), formerly PVI Solutions, Inc., is an energy management solutions provider that designs, develops, manufactures and sells microinverter system. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electric …
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Vanderbilt University Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Vanderbilt University Medical Center (VUMC), a subsidiary of Vanderbilt University is a healthcare service provider that offers patient care, research and bio-medical education. The center’s services include adult emergency services, case management, corporate health services, adult psychiat …
  • UnionBank of the Philippines (UBP):企業の財務・戦略的SWOT分析
    UnionBank of the Philippines (UBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • McLean Electric Cooperative Inc:企業の戦略的SWOT分析
    McLean Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Straumann Holding AG (STMN):企業の財務・戦略的SWOT分析
    Straumann Holding AG (STMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Autolus Therapeutics Plc (AUTL):製薬・医療:M&Aディール及び事業提携情報
    Summary Autolus Therapeutics Plc (Autolus), formerly Autolus Therapeutics Limited is a clinical-stage biopharmaceutical company which offers programmed T cell immunotherapies for the treatment of hematological cancers and solid tumors. The company utilizes its T-cell programming and manufacturing te …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆